Dueling Fools: Johnson & Johnson
12361
No more tears, my friend. We're talking about J&J now.
494566
NEW YORK McCann Erickson&#39;s loss of most of its Johnson & Johnson business last week is a significant blow to parent Interpublic Group--and the erosion may not be over. Interpublic&#39;s J&J losses could also spell big gains for WPP and Omnicom.
378404
Charges hurt the quarterly results of  Johnson & Johnson, Merck & Co. and Schering-Plough Corp., but  the drugmakers' shares rose as J&J's earnings beat Wall Street  forecasts and Merck sales edged higher despite the withdrawal  of its best-selling Vioxx arthritis drug.
368114
Johnson &amp; Johnson announced last night that will buy medical-device maker Guidant for $23.9 billion in cash and stock. The deal, approved by both boards but subject to regulator approval, is one of the largest
743979
Johnson & Johnson said it believed that its non-American subsidiaries had made improper payments in connection with the sale of medical devices in two small-market countries.
340033
Johnson & Johnson is in advanced negotiations to acquire Guidant, one of the nation's largest makers of devices to treat heart illnesses, for more than $24 billion.
95065
Credit Suisse First Boston maintained &quot;neutral&quot; ratings on Guidant (nyse: GDT - news - people ) and Johnson &amp; Johnson (nyse: JNJ - news - people ), saying a near-term acquisition of the former by the latter values Guidant at $76.
538628
The latest earnings report from jam specialist JM Smucker (NYSE: SJM) heralds &quot;Record First Quarter Results.&quot; Read carefully, though.
351599
NEW YORK -- Johnson &amp; Johnson will acquire Guidant Corp., one of the world&#39;s leading makers of cardiac devices, for about $25.4 billion in cash and stock.
32462
Johnson &amp; Johnson, the US medical and consumer goods group, is in advanced discussions to buy Guidant, a maker of medical devices, in a deal that could be worth about $24bn (Â£12bn).
148143
Johnson & Johnson JNJ.N has sued   Boston Scientific BSX.N and Abbott Laboratories Inc. ABT.N,   seeking at least $5.5 billion in damages related to J&J's   failed bid to acquire medical device maker Guidant Corp.
249844
CHICAGO/PHILADELPHIA  - Health care and consumer  products maker Johnson & Johnson JNJ.N is in negotiations to  acquire medical-device maker Guidant Corp. GDT.N, sources  familiar with the situation said on Tuesday.
584943
Johnson & Johnson  has sued  Boston Scientific  and Abbott Laboratories Inc. ,  seeking at least $5.5 billion in damages related to J&J's  failed bid to acquire medical device maker Guidant Corp.
557571
A long-anticipated merger may soon come true.
225711
Johnson &amp; Johnson has made dozens of mostly small acquisitions over the last decade, expanding its portfolio of more than 200 businesses that make products like Band-Aids, artificial knees and blockbuster drugs.
584724
Johnson &amp; Johnson (JNJ), the drug and health care products company, is reportedly in advanced negotiations to buy Guidant (GDT), a leading maker of devices to treat heart and circulatory illnesses, for more than $24 billion.
552235
"Buy 'em both" is not exactly the strongest defense.